Triamcinolone Acetonide as an Adjunct to Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model
Purpose: To evaluate the short-term effects of a single subconjunctival injection of triamcinolone acetonide as an adjunct to subconjunctival bevacizumab for prevention of corneal neovascularization in rats. Methods: Chemical cauterization was performed in the central cornea of the right eye in 48...
Main Authors: | Hadi Z Mehrjardi, Reza Ghaffari, Mirgholamreza Mahbod, Hassan Hashemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2014-01-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | http://www.jovr.org/article.asp?issn=2008-322X;year=2014;volume=9;issue=2;spage=162;epage=168;aulast=Mehrjardi |
Similar Items
-
Intralesional injection of bevacizumab versus triamcinolone acetonide in infantile hemangioma
by: Hanan H. Sabry, et al.
Published: (2020-04-01) -
Intravitreal bevacizumab versus bevacizumab and 1 mg triamcinolone acetonide in eyes with bilateral diabetic macular edema
by: Sever Ozkan, et al.
Published: (2019-01-01) -
Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01) -
Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization
by: Hyeon Jeong Yoon, et al.
Published: (2019-11-01) -
Suprachoroidal injection of triamcinolone acetonide plus intravitreal bevacizumab in diabetic macular edema: a randomized pilot trial
by: Farhad Fazel, et al.
Published: (2023-01-01)